Product Details
HERCEPTIN SOLUTION FOR INJECTION (FOR SUBCUTANEOUS USE)*
Trastuzumab hyaluronidase (SC formulation)600 mg
Injection
ROA
Subcutaneous
Applicant Name
Roche Products Limited
NRN
A6-0481
Status
Active
Composition
ATC Code
L01FD01
Product Category
Vaccines and Biologics
Marketing Category
Prescription-only Medicine (POM)
Packsize
1 X 1
Product Description
4 RNW-BV-313463 HERCEPTIN SOLUTION FOR INJECTION (FOR SUBCUTANEOUS USE) TRASTUZUMAB Trastuzumab sc 600 mg, Recombinant human hyaluronidase (rHuPH20) 10 000 U, L-Histidine 1.95 mg, L-Histidine hydrochloride monohydrate 18.35 mg, a,a-Trehalose dihydrate 397.25 mg, L-Methionine 7.45 mg, Polysorbate 20 2.0 mg, Water q.s.2 to 5.0 mL A6-0481 Vaccines & Biologicals Biologics Imported Products 1*1 2/7/2023 ROCHE PRODUCTS LIMITED, 2nd Floor, 48/50 Isaac John Street Ikeja GRA, Lagos. 8056292219 angela.essien@roche.com F. Hoffmann La Roche Ltd, Wurmisweg 4303, Kaiseraugst Switzerland., F. Hoffmann La Roche Ltd, Wurmisweg 4303, Kaiseraugst Switzerland., Switzerland
Manufacturer Name
F Hoffman La-Roche Ltd
Manufacturer Country
SWITZERLAND
Approval Date
2023-07-03
Expiry Date
2028-07-02